Frontiers in Oncology · 2022 · 15 citations · 20 references
MedicineMolecular BiologyOncologyCell SignalingMetastasisMolecular OncologyCancer Cell SignalingMetastatic Signaling PathwaysOncogenic Signaling PathwaysSignal Transduction In CancerCancer Signaling PathwaysF-box Protein RegulationHepatocellular Carcinoma MetastasisHepatocellular Carcinoma PathogenesisOncogenic TransformationZinc Finger DomainsZinc Finger MotifsZinc Finger Proteins
F-box proteins are critical for malignancy because they control the turnover of key proteins that govern multiple cellular processes. F-box protein 9 (FBXO9) belongs to the F-box protein family and exhibits oncogenic properties in hematological malignancies. However, the function and molecular mechanism of FBXO9 in hepatocellular carcinoma (HCC) remain unclear. Here, we report that FBXO9 was remarkably overexpressed in HCC. Loss- and gain-of-function experiments showed that FBXO9 facilitates HCC cell proliferation and metastasis both in vitro and in vivo . Mechanistically, as a direct upstream transcription factor, FBXO9 is regulated by zinc finger protein 143 (ZNF143) and accelerates tumor growth and metastasis by targeting the F-box and WD repeat domain containing 7 (FBXW7) for ubiquitination and degradation. Additionally, we found that with FBXO9 knockdown, HCC cells were more sensitive to treatment with lenvatinib and sorafenib. In summary, our results demonstrate that a ZNF143-FBXO9-FBXW7 signaling regulatory axis may be involved in tumor progression in HCC, and suggest that FBXO9 could be a potential biomarker and therapeutic target for HCC.
20
The MAP3K13-TRIM25-FBXW7α axis affects c-Myc protein stability and tumor development
Qiang Zhang, Li Xu, Kasa Cui et al. · Cell Death and Differentiation · 2019 · 128 citations · Full text
FBXO22 degrades nuclear PTEN to promote tumorigenesis
Meng-Kai Ge, Na Zhang, Xia Li et al. · Nature Communications · 2020 · 112 citations · Full text